1-9 A-D E-G H-M N-P Q-S T-Z

SODIUM XYLENE SULFONATE (SODYUM KSİLEN SULFONAT)

SODIUM XYLENE SULFONATE (SODYUM KSİLEN SÜLFONAT)

CAS NO: 1300-72-7

 

SYNONYMS: SODIUM XYLENE SULFONATE; SODIUM XYLENE SULPHONATE; SODYUM KSİLEN SULFONAT; SODYUM KSİLEN SULPHONATE; SODYUM KSİLENE SULPHONATE; sodium xylene sulfonate; FT-0657395 benzenesulfonic acid; KSİLEN; KSİLEM SULFONAT; KSİLEN SULPHONAT; KSİLEN SULPHONATE; HİDROTROP; NANOTAKS; PENTOSAN SULFATE SODYUM; ELTESOL SXS30 ; Sodium xylene sulfonate; 3,4-dimethyl-; sodium salt; benzenesulfonic acid; 3,4-dimethyl-; sodium salt; benzenesulfonic acid; dimethyl-; sodium salt; conco SXS; cyclophil SXS30; dimethylbenzenesulfonic acid, sodium salt; dimethylbenzenesulfonic acid, sodium salt; eltesol SX 30; naxonate; sodium xylene sulfonate; G richonate; SXS; sodium 3,4-dimethylbenzenesulfonate; sodium xylenesulfonate; sodium xylenesulphonate sodium; 3,4-dimethylbenzenesulfonate; stepanate X; surco SXS; ultrawet 40SX; xylenesulfonic acid; sodium salt; Ammonium xylenesulfonate; Sodium xylenesulfonate; sodium dimethylbenzenesulfonate; NAXONATE SX; XYLENESULFONIC ACID,SODIUM SALT; NAXOLATE 4LS; NAXONATE 4L; NAXONATE 5L; SXS; Benzenesulfonic acid; dimethyl-; sodium salt; Dimethylbenzenesulfonic acid; sodium salt; Pentosan polysulfate sodium; Sodium xylenesulfonate; Benzenesulfonic acid, dimethyl-, sodium salt; Caswell No. 799A; CCRIS 4893; Conco SXS; sodium xylene sulfonate;Cyclophil sxs30; EC 215-090-9; EINECS 215-090-9; sodium xylene sulfonate;Eltesol SX 30; EPA Pesticide Chemical Code 079019; HSDB 776; Hydrotrope; Naxonate; Naxonate G; NCI-C55403; sodium xylene sulfonate; sodium xylene sulfonate;Richonate SXS; Sodium dimethylbenzenesulfonate; Sodium xylenesulfonate; Stepanate X; Surco SXS; Ultrawet 40SX; UNII-G4LZF950UR; Xylenesulfonic acid; sodium salt; SXS; surcosxs; naxonate; concosxs; naxonateg; sodium xylene sulfonate; stepanatex; sodium xylene sulfonate;nci-c55403; hydrotrope; eltesolsx30; NAXONATE 4L; Sodium sulfate; Antirust agent; T702 8-CHLOROADENOSINE-3',5'-CYCLIC MONOPHOSPHOROTHIOATE; sodium xylene sulfonate;RP-ISOMER; SODIUM SALT; Sodium 3-nitrobenzenesulphonate; ACID BLUE 40; sodium xylene sulfonate;REACTIVE BLACK; 5 ACID BLUE; sodium xylene sulfonate;25 COPPER PHTHALOCYANINE; TETRASULFONIC ACID; TETRASODIUM SALT; Sodium anthraquinone-2-sulfonate; sodium xylene sulfonate;ACID BLUE 41; UNIBLUE A SODIUM SALT; ANTHRAQUINONE-2,6-DISULFONIC ACID; DISODIUM SALT; sodium xylene sulfonate; Sodium xylenesulfonate; Sodium benzoate; 2-METHYL-2-PROPENE-1-SULFONIC ACID; SODIUM SALT; sSodium lignosulfonate; sodium xylene sulfonate;Sodium citrate; eltesolsx30; hydrotrope; naxonate; eltesol sx 30; hydrotrope; naxonate; naxonateg; nci-c55403; richonatesxs; stepanatex; surcosxs; sodium xylene sulfonate; sodyum ksilen sülfonat, solubilizer; eltesol sx 40; sodyum; ksilen; sülfonat; cas no : 1300-27-7; sodium xylene sulfonate;Benzenesulfonic acid; sodium xylene sulfonate; dimethyl-; sodium salt ( Benzensülfonik asit; dimetil sodyum tuzu; Dimethylbenzenesulfonate; ( Sodyum Dimetilbenzensülfonat ); sodium xylene sulfonate; sodyum ksilen sülfonat; solubilizer; eltesol sx 40; sodyum ksilen; sülfonat; cas no : 1300-27-7; Benzenesulfonic acid; dimethyl-; sodium salt ( Benzensülfonik asit; dimetil sodyum tuzu ); Sodium Dimethylbenzenesulfonat; ( Sodyum Dimetilbenzensülfonat ); NAXOLATE 4LS; NAXONATE 4L; NAXONATE 5L; NAXONATE SX; SODIUM XYLENESULFONATE; sodium dimethylbenzenesulfonate; SXS; XYLENESULFONIC ACID; SODIUM SALT; benzensülfonik asit; sodium xylene sulfonate; sodyum ksilen sülfonat; sodyumksilen sülfonat; sodyum ksilensülfonat; sodium; xylene; sodium xylene sulfonate; sulfonate; sulphonate; sodiumxylenesulfonate; sodium xylenesulfonate; sodiumxylene sulfonate; Ammonium xylenesulfonate; Sodium xylenesulfonate; sodium dimethylbenzenesulfonate; NAXONATE SX; XYLENESULFONIC ACID,SODIUM SALT; NAXOLATE 4LS; NAXONATE 4L; NAXONATE 5L; SXS; Benzenesulfonic acid; dimethyl-; sodium salt; Dimethylbenzenesulfonic acid; sodium salt; SODIUM XYLENE SULFONATE; SODYUM KSILEN SULFONAT; SODIUM; SODYUM; KSILEN; KISILEN; KİSİLEN; SULFONAT; SULFONATE; SODYUM KSILEN; SODIUM XYLENE; KSİLEN SÜLFONAT; XYLENE SULFONATE; XYLEN; XYLENE; KSILEN SODIUM; KSILEN SODYUM; XYLENE SULFONAT; SULFAT; XYLEN SULFAT; XYLEEN; sodıum xylene sulfonate; sodyum ksılen sulfonat; sodıum; sodyum; ksılen; kısılen; kisilen; sulfonat; sulfonate; sodyum ksılen; sodıum xylene; ksilen sülfonat; xylene sulfonate; xylen; xylene; ksılen sodıum; ksılen sodyum; xylene sulfonat; sulfat; xylen sulfat; xyleen; sodyum kxsilen sulfonate; sulphonate xilen;sodyum kxyilen sulfonat; sodyum kxyilen sulfonate; sodyum kxsilen sulfonat; sodyum kxsilen sulfat; sodyum kxyilen sulfat; sodyum kxyilen sulfate; sodyum kxyilen sülfat; sodyum kxyilen sülfate; sodyum kxyilen sülfonat; sodyum kxyilen sülfonate; sodyum kxsilen sülfonate; sodyum kxsilen sülfonat; sodyum kxsilen sülfat; sodyum kxsilen sülfate; kxsil; kxsilen; kxsilene; kxylen; kxylene; kxiylen; kxyilene; sodyum kxsil; sodyum kxsilen; sodyum kxsilene; sodyum kxylen; sodyum kxylene; sodyum kxiylen; sodyum kxyilene; sodyum kxsil sülfat;sodyum kxsil sülfate; sodyum kxsil sülfonate; sodyum kxsil sülfonat; sodyum kxsil sulfat; sodyum kxsil sulfate; sodyum kxsil sulfonate; sodyum kxsil sulfat; sodyum kxsilen; sodyum kxsilene; sodyum kxylen; sodyum kxylene; sodyum kxiylen; sodyum kxyilene; sodyum kxsilen sülfat; sodyum kxsilen sülfate; sodyum kxsilen sülfonate; sodyum kxsilen sülfonat; sodyum kxsilen sulfat; sodyum kxsilen sulfate; sodyum kxsilen sulfonate; sodyum kxsilen sülfat; sodyum kxsilen sülfate; sodyum kxsilen sülfonate; sodyum kxsilen sülfonat; sodyum kxsilene sülfat; sodyum kxsilene sülfate; sodyum kxsilene sülfonate; sodyum kxsilene sülfonat; sodyum kxsilene sulfat; sodyum kxsilene sulfate; sodyum kxsilene sulfonate; sodyum kxsilene sulfat; sodyum kxylen sülfat; sodyum kxylen sülfate; sodyum kxylen sülfonate; sodyum kxylen sülfonat; sodyum kxylen sulfat; sodyum kxylen sulfate; sodyum kxylen sulfonate; sodyum kxylen sulfonat; sodyum kxylene sülfat; sodyum kxylene sülfate; sodyum kxylene sülfonate; sodyum kxylene sülfonat; sodyum kxylene sulfat; sodyum kxylene sulfate; sodyum kxylene sulfonate; sodyum kxylene sulfonat; sodyum kxiylen sülfat; sodyum kxiylen sülfate; sodyum kxiylen sülfonate; sodyum kxiylen sülfonat; sodyum kxiylen sulfat; sodyum kxiylen sulfate; sodyum kxiylen sulfonat; sodyum kxiylen sulfonat; sodyum kxyilene sülfat; sodyum kxyilene sülfate; sodyum kxyilene sülfonate; sodyum kxyilene sülfonat; sodyum kxyilene sulfat; sodyum kxyilene sulfate; sodyum kxyilene sulfonate; sodyum kxyilene sulfonat; kxsil sülfat; kxsil sülfate; kxsil sülfonate; kxsil sülfonat; kxsil sulfat; sodyum kxsil sulfate; kxsil sulfonate; kxsil sulfat; kxsilen; kxsilene; kxylen; kxylene; kxiylen; kxyilene; kxsilen sülfat; kxsilen sülfate; kxsilen sülfonate; kxsilen sülfonat; kxsilen sulfat; kxsilen sulfate; kxsilen sulfonate; kxsilen sülfat; kxsilen sülfate; sodyum kxsilen sülfonate; kxsilen sülfonat; kxsilene sülfat; kxsilene sülfate; kxsilene sülfonate; kxsilene sülfonat; kxsilene sulfat; kxsilene sulfate; sodyum kxsilene sulfonate; kxsilene sulfat; kxylen sülfat; kxylen sülfate; kxylen sülfonate; kxylen sülfonat; kxylen sulfat; kxylen sulfate; kxylen sulfonate; kxylen sulfonat; kxylene sülfat; kxylene sülfate; kxylene sülfonate; kxylene sülfonat; kxylene sulfat; kxylene sulfate; sodyum kxylene sulfonate; kxylene sulfonat; kxiylen sülfat; kxiylen sülfate; kxiylen sülfonate; kxiylen sülfonat; kxiylen sulfat; kxiylen sulfate; sodyum kxiylen sulfonate; kxiylen sulfonat; kxyilene sülfat; kxyilene sülfate; kxyilene sülfonate; kxyilene sülfonat; kxyilene sulfat; kxyilene sulfate; kxyilene sulfonate; kxyilene sulfonat; sodiyum kxsil sülfat; sodiyum kxsil sülfate; sodiyum kxsil sülfonate; sodiyum kxsil sülfonat; sodiyum kxsil sulfat; sodiyum kxsil sulfate; sodiyum kxsil sulfonate; sodiyum kxsil sulfat; sodiyum kxsilen; sodiyum kxsilene; sodiyum kxylen; sodiyum kxylene; sodyum kxiylen; sodiyum kxyilene; sodiyum kxsilen sülfat; sodiyum kxsilen sülfate; sodiyum kxsilen sülfonate; sodiyum kxsilen sülfonat; sodiyum kxsilen sulfat; kxsilen sulfate; sodiyum kxsilen sulfonate; sodiyum kxsilen sülfat; sodiyum kxsilen sülfate; sodiyum kxsilen sülfonate; sodiyum kxsilen sülfonat; sodiyum kxsilene sülfat; sodiyum kxsilene sülfate; sodiyum kxsilene sülfonate; sodiyum kxsilene sülfonat; sodiyum kxsilene sulfat; sodiyum kxsilene sulfate; sodiyum kxsilene sulfonate; sodiyum kxsilene sulfat; sodiyum kxylen sülfat; sodiyum kxylen sülfate; sodiyum kxylen sülfonate; sodiyum kxylen sülfonat; sodiyum kxylen sulfat; sodiyum kxylen sulfate; sodiyum kxylen sulfonate; sodiyum kxylen sulfonat; sodiyum kxylene sülfat; sodiyum kxylene sülfate; sodiyum kxylene sülfonate; sodiyum kxylene sülfonat; sodiyum kxylene sulfat; sodiyum kxylene sulfate; sodiyum kxylene sulfonate; sodiyum kxylene sulfonat; sodiyum kxiylen sülfat; sodiyum kxiylen sülfate; sodiyum kxiylen sülfonate; sodiyum kxiylen sülfonat; sodiyum kxiylen sulfat; sodiyum kxiylen sulfate; sodiyum kxiylen sulfonate; sodiyum kxiylen sulfonat; sodiyum kxyilene sülfat; sodiyum kxyilene sülfate; sodiyum kxyilene sülfonate; sodiyum kxyilene sülfonat; sodiyum kxyilene sulfat; sodiyum kxyilene sulfate; sodiyum kxyilene sulfonate; sodiyum kxyilene sulfonat;; sodiyumkxsilsülfat; sodiyumkxsilsülfate; sodiyumkxsil sülfonate; sodiyumkxsil sülfonat; sodiyumkxsilsulfat; sodiyumkxsilsulfate; sodiyumkxsilsulfonate; sodiyumkxsilsulfat; sodiyumkxsilen; sodiyumkxsilene; sodiyumkxylen; sodiyumkxylene; sodyumkxiylen; sodiyumkxyilene; sodiyumkxsilensülfat; sodiyumkxsilen sülfate; sodiyum kxsilen sülfonate; sodiyumkxsilen sülfonat; sodiyumkxsilensulfat; kxsilensulfate; sodiyumkxsilen sulfonate; sodiyum kxsilen sülfat; sodiyumkxsilen sülfate; sodiyumkxsilensülfonate; sodiyumkxsilensülfonat; sodiyumkxsilenesülfat; sodiyumkxsilene sülfate; sodiyumkxsilene sülfonate; sodiyumkxsilene sülfonat; sodiyumkxsilene sulfat; sodiyum kxsilene ulfate; sodiyumkxsilene sulfonate; sodiyum kxsilenesulfat; sodiyumkxylensülfat; sodiyumkxylen sülfate; sodiyumkxylen sülfonate; sodiyum kxylensülfonat; sodiyumkxylen sulfat; sodiyumkxylen sulfate; sodiyumkxylensulfonate; sodiyumkxylen sulfonat; sodiyumkxylenesülfat; sodiyumkxylene sülfate; sodiyumkxylene sülfonate; sodiyum kxylenesülfonat; sodiyumkxylenesulfat; sodiyumkxylene sulfate; sodiyumkxylene sulfonate; sodiyumkxylenesulfonat; sodiyumkxiylensülfat; sodiyumkxiylen sülfate; sodiyumkxiylen sülfonate; sodiyum kxiylensülfonat; sodiyumkxiylen ulfat; sodiyumkxiylen sulfate; sodiyumkxiylen sulfonate; sodiyumkxiylensulfonat; sodiyumkxyilenesülfat; sodiyumkxyilene sülfate; sodiyumkxyilene sülfonate; sodiyum kxyilenesülfonat; sodiyumkxyilenesulfat; sodiyumkxyilenesulfate; sodiyumkxyilene sulfonate; sodiyumkxyilene sulfonat; SODIUM XYLENE SULFONATE; SODYUM KSILEN SULFONAT; SODIUM; SODYUM; KSILEN; KISILEN; KISILEN; SULFONAT; SULFONATE; SODYUM KSILEN; SODIUM XYLENE; KSILEN SÜLFONAT; XYLENE SULFONATE; XYLEN; XYLENE; KSILEN SODIUM; KSILEN SODYUM; XYLENE SULFONAT; SULFAT; XYLEN SULFAT; XYLEEN; SODYUM KXSILEN SULFONATE; SULPHONATE XILEN;SODYUM KXYILEN SULFONAT; SODYUM KXYILEN SULFONATE; SODYUM KXSILEN SULFONAT; SODYUM KXSILEN SULFAT; SODYUM KXYILEN SULFAT; SODYUM KXYILEN SULFATE; SODYUM KXYILEN SÜLFAT; SODYUM KXYILEN SÜLFATE; SODYUM KXYILEN SÜLFONAT; SODYUM KXYILEN SÜLFONATE; SODYUM KXSILEN SÜLFONATE; SODYUM KXSILEN SÜLFONAT; SODYUM KXSILEN SÜLFAT; SODYUM KXSILEN SÜLFATE; KXSIL; KXSILEN; KXSILENE; KXYLEN; KXYLENE; KXIYLEN; KXYILENE; SODYUM KXSIL; SODYUM KXSILEN; SODYUM KXSILENE; SODYUM KXYLEN; SODYUM KXYLENE; SODYUM KXIYLEN; SODYUM KXYILENE; SODYUM KXSIL SÜLFAT;SODYUM KXSIL SÜLFATE; SODYUM KXSIL SÜLFONATE; SODYUM KXSIL SÜLFONAT; SODYUM KXSIL SULFAT; SODYUM KXSIL SULFATE; SODYUM KXSIL SULFONATE; SODYUM KXSIL SULFAT; SODYUM KXSILEN; SODYUM KXSILENE; SODYUM KXYLEN; SODYUM KXYLENE; SODYUM KXIYLEN; SODYUM KXYILENE; SODYUM KXSILEN SÜLFAT; SODYUM KXSILEN SÜLFATE; SODYUM KXSILEN SÜLFONATE; SODYUM KXSILEN SÜLFONAT; SODYUM KXSILEN SULFAT; SODYUM KXSILEN SULFATE; SODYUM KXSILEN SULFONATE; SODYUM KXSILEN SÜLFAT; SODYUM KXSILEN SÜLFATE; SODYUM KXSILEN SÜLFONATE; SODYUM KXSILEN SÜLFONAT; SODYUM KXSILENE SÜLFAT; SODYUM KXSILENE SÜLFATE; SODYUM KXSILENE SÜLFONATE; SODYUM KXSILENE SÜLFONAT; SODYUM KXSILENE SULFAT; SODYUM KXSILENE SULFATE; SODYUM KXSILENE SULFONATE; SODYUM KXSILENE SULFAT; SODYUM KXYLEN SÜLFAT; SODYUM KXYLEN SÜLFATE; SODYUM KXYLEN SÜLFONATE; SODYUM KXYLEN SÜLFONAT; SODYUM KXYLEN SULFAT; SODYUM KXYLEN SULFATE; SODYUM KXYLEN SULFONATE; SODYUM KXYLEN SULFONAT; SODYUM KXYLENE SÜLFAT; SODYUM KXYLENE SÜLFATE; SODYUM KXYLENE SÜLFONATE; SODYUM KXYLENE SÜLFONAT; SODYUM KXYLENE SULFAT; SODYUM KXYLENE SULFATE; SODYUM KXYLENE SULFONATE; SODYUM KXYLENE SULFONAT; SODYUM KXIYLEN SÜLFAT; SODYUM KXIYLEN SÜLFATE; SODYUM KXIYLEN SÜLFONATE; SODYUM KXIYLEN SÜLFONAT; SODYUM KXIYLEN SULFAT; SODYUM KXIYLEN SULFATE; SODYUM KXIYLEN SULFONAT; SODYUM KXIYLEN SULFONAT; SODYUM KXYILENE SÜLFAT; SODYUM KXYILENE SÜLFATE; SODYUM KXYILENE SÜLFONATE; SODYUM KXYILENE SÜLFONAT; SODYUM KXYILENE SULFAT; SODYUM KXYILENE SULFATE; SODYUM KXYILENE SULFONATE; SODYUM KXYILENE SULFONAT; KXSIL SÜLFAT; KXSIL SÜLFATE; KXSIL SÜLFONATE; KXSIL SÜLFONAT; KXSIL SULFAT; SODYUM KXSIL SULFATE; KXSIL SULFONATE; KXSIL SULFAT; KXSILEN; KXSILENE; KXYLEN; KXYLENE; KXIYLEN; KXYILENE; KXSILEN SÜLFAT; KXSILEN SÜLFATE; KXSILEN SÜLFONATE; KXSILEN SÜLFONAT; KXSILEN SULFAT; KXSILEN SULFATE; KXSILEN SULFONATE; KXSILEN SÜLFAT; KXSILEN SÜLFATE; SODYUM KXSILEN SÜLFONATE; KXSILEN SÜLFONAT; KXSILENE SÜLFAT; KXSILENE SÜLFATE; KXSILENE SÜLFONATE; KXSILENE SÜLFONAT; KXSILENE SULFAT; KXSILENE SULFATE; SODYUM KXSILENE SULFONATE; KXSILENE SULFAT; KXYLEN SÜLFAT; KXYLEN SÜLFATE; KXYLEN SÜLFONATE; KXYLEN SÜLFONAT; KXYLEN SULFAT; KXYLEN SULFATE; KXYLEN SULFONATE; KXYLEN SULFONAT; KXYLENE SÜLFAT; KXYLENE SÜLFATE; KXYLENE SÜLFONATE; KXYLENE SÜLFONAT; KXYLENE SULFAT; KXYLENE SULFATE; SODYUM KXYLENE SULFONATE; KXYLENE SULFONAT; KXIYLEN SÜLFAT; KXIYLEN SÜLFATE; KXIYLEN SÜLFONATE; KXIYLEN SÜLFONAT; KXIYLEN SULFAT; KXIYLEN SULFATE; SODYUM KXIYLEN SULFONATE; KXIYLEN SULFONAT; KXYILENE SÜLFAT; KXYILENE SÜLFATE; KXYILENE SÜLFONATE; KXYILENE SÜLFONAT; KXYILENE SULFAT; KXYILENE SULFATE; KXYILENE SULFONATE; KXYILENE SULFONAT; SODIYUM KXSIL SÜLFAT; SODIYUM KXSIL SÜLFATE; SODIYUM KXSIL SÜLFONATE; SODIYUM KXSIL SÜLFONAT; SODIYUM KXSIL SULFAT; SODIYUM KXSIL SULFATE; SODIYUM KXSIL SULFONATE; SODIYUM KXSIL SULFAT; SODIYUM KXSILEN; SODIYUM KXSILENE; SODIYUM KXYLEN; SODIYUM KXYLENE; SODYUM KXIYLEN; SODIYUM KXYILENE; SODIYUM KXSILEN SÜLFAT; SODIYUM KXSILEN SÜLFATE; SODIYUM KXSILEN SÜLFONATE; SODIYUM KXSILEN SÜLFONAT; SODIYUM KXSILEN SULFAT; KXSILEN SULFATE; SODIYUM KXSILEN SULFONATE; SODIYUM KXSILEN SÜLFAT; SODIYUM KXSILEN SÜLFATE; SODIYUM KXSILEN SÜLFONATE; SODIYUM KXSILEN SÜLFONAT; SODIYUM KXSILENE SÜLFAT; SODIYUM KXSILENE SÜLFATE; SODIYUM KXSILENE SÜLFONATE; SODIYUM KXSILENE SÜLFONAT; SODIYUM KXSILENE SULFAT; SODIYUM KXSILENE SULFATE; SODIYUM KXSILENE SULFONATE; SODIYUM KXSILENE SULFAT; SODIYUM KXYLEN SÜLFAT; SODIYUM KXYLEN SÜLFATE; SODIYUM KXYLEN SÜLFONATE; SODIYUM KXYLEN SÜLFONAT; SODIYUM KXYLEN SULFAT; SODIYUM KXYLEN SULFATE; SODIYUM KXYLEN SULFONATE; SODIYUM KXYLEN SULFONAT; SODIYUM KXYLENE SÜLFAT; SODIYUM KXYLENE SÜLFATE; SODIYUM KXYLENE SÜLFONATE; SODIYUM KXYLENE SÜLFONAT; SODIYUM KXYLENE SULFAT; SODIYUM KXYLENE SULFATE; SODIYUM KXYLENE SULFONATE; SODIYUM KXYLENE SULFONAT; SODIYUM KXIYLEN SÜLFAT; SODIYUM KXIYLEN SÜLFATE; SODIYUM KXIYLEN SÜLFONATE; SODIYUM KXIYLEN SÜLFONAT; SODIYUM KXIYLEN SULFAT; SODIYUM KXIYLEN SULFATE; SODIYUM KXIYLEN SULFONATE; SODIYUM KXIYLEN SULFONAT; SODIYUM KXYILENE SÜLFAT; SODIYUM KXYILENE SÜLFATE; SODIYUM KXYILENE SÜLFONATE; SODIYUM KXYILENE SÜLFONAT; SODIYUM KXYILENE SULFAT; SODIYUM KXYILENE SULFATE; SODIYUM KXYILENE SULFONATE; SODIYUM KXYILENE SULFONAT;; SODIYUMKXSILSÜLFAT; SODIYUMKXSILSÜLFATE; SODIYUMKXSIL SÜLFONATE; SODIYUMKXSIL SÜLFONAT; SODIYUMKXSILSULFAT; SODIYUMKXSILSULFATE; SODIYUMKXSILSULFONATE; SODIYUMKXSILSULFAT; SODIYUMKXSILEN; SODIYUMKXSILENE; SODIYUMKXYLEN; SODIYUMKXYLENE; SODYUMKXIYLEN; SODIYUMKXYILENE; SODIYUMKXSILENSÜLFAT; SODIYUMKXSILEN SÜLFATE; SODIYUM KXSILEN SÜLFONATE; SODIYUMKXSILEN SÜLFONAT; SODIYUMKXSILENSULFAT; KXSILENSULFATE; SODIYUMKXSILEN SULFONATE; SODIYUM KXSILEN SÜLFAT; SODIYUMKXSILEN SÜLFATE; SODIYUMKXSILENSÜLFONATE; SODIYUMKXSILENSÜLFONAT; SODIYUMKXSILENESÜLFAT; SODIYUMKXSILENE SÜLFATE; SODIYUMKXSILENE SÜLFONATE; SODIYUMKXSILENE SÜLFONAT; SODIYUMKXSILENE SULFAT; SODIYUM KXSILENE SULFATE; SODIYUMKXSILENE SULFONATE; SODIYUM KXSILENESULFAT; SODIYUMKXYLENSÜLFAT; SODIYUMKXYLEN SÜLFATE; SODIYUMKXYLEN SÜLFONATE; SODIYUM KXYLENSÜLFONAT; SODIYUMKXYLEN SULFAT; SODIYUMKXYLEN SULFATE; SODIYUMKXYLENSULFONATE; SODIYUMKXYLEN SULFONAT; SODIYUMKXYLENESÜLFAT; SODIYUMKXYLENE SÜLFATE; SODIYUMKXYLENE SÜLFONATE; SODIYUM KXYLENESÜLFONAT; SODIYUMKXYLENESULFAT; SODIYUMKXYLENE SULFATE; SODIYUMKXYLENE SULFONATE; SODIYUMKXYLENESULFONAT; SODIYUMKXIYLENSÜLFAT; SODIYUMKXIYLEN SÜLFATE; SODIYUMKXIYLEN SÜLFONATE; SODIYUM KXIYLENSÜLFONAT; SODIYUMKXIYLEN ULFAT; SODIYUMKXIYLEN SULFATE; SODIYUMKXIYLEN SULFONATE; SODIYUMKXIYLENSULFONAT; SODIYUMKXYILENESÜLFAT; SODIYUMKXYILENE SÜLFATE; SODIYUMKXYILENE SÜLFONATE; SODIYUM KXYILENESÜLFONAT; SODIYUMKXYILENESULFAT; SODIYUMKXYILENESULFATE; SODIYUMKXYILENE SULFONATE; SODIYUMKXYILENE SULFONAT


Chemical Identity
Name: Sodium xylene sulfonate
Brand Names: Not applicable
Chemical name (IUPAC): Sodium dimethylbenzenesulfonate
CAS number(s): 1300-72-7
EC number: 215-090-9
Molecular formula: C8H9NaO3S


Uses and Applications
Sodium xylene sulfonate is used in liquid household detergents and shampoos, in degreasing compounds and printing pastes used in the textile industry. It is also a surfactant found in personal care products, primarily in shampoos, sodium xylene sulfonate because of its ability to serve as a claritant or wetting agent sodium xylene sulfonate that helps a formula spread more easily. Sodium xylene sulfonate is also used to extract pentosans and lignin in the paper industry, and as a glue additive in the leather sodium xylene sulfonate industryExposure, Hazard and Safety Assessment The following section describes possible exposure scenarios and hazards associated with sodium xylene sulfonate. The exposure sodium xylene sulfonate assessment describes both the amount of and the frequency with which a chemical substance reaches a person, a population of people, or the environment. Hazard refers to the inherent properties of a substance that make it capable of causing harm to human health or the environment. The safety assessment reports the possibility of a harmful event arising from exposure to a chemical or physical agent under specific conditions. Just because a substance may possess potentially harmful properties does not mean that it automatically poses a risk. It is not possible to make that determination without understanding the exposure. Human Health Effects Human Exposure Assessment Consumer: Sodium xylene sulfonate is used in liquid household detergents and shampoos. Therefore, consumer oral and dermal exposures could occur when using products that contain sodium xylene sulfonate in the product formulations. Worker: In industrial settings, sodium xylene sulfonate is manufactured and handled in closed processes as much as possible, which ensures that worker exposure is minimized.

 

 


When there is potential for exposure, during loading, sodium xylene sulfonate unloading, sampling or during maintenance operations, exposure to sodium xylene sulfonate can be further sodium xylene sulfonate minimized by the proper use of personal protective equipment. Human Hazard Assessment Sodium xylene sulfonate is low for both acute and repeat dose toxicity. It can cause eye irritation but is not anticipated to result in skin irritation or sensitization. Sodium xylene sulfonate is not associated with reproductive sodium xylene sulfonate toxicity, genotoxicity/mutagenicity or carcinogenicity. Human Health Safety Assessment Consumer: Sodium xylene sulfonate is used in liquid household detergents and shampoos. Risk to human health following exposure is unlikely due to the low toxicity of this material.

 

 

Direct contact with the eyes should be avoided. Worker: In industrial settings, sodium xylene sulfonate is manufactured and handled primarily in closed processes which limit exposure. Based on good manufacturing processes and industrial hygiene sodium xylene sulfonate, the occupational health risk associated with sodium xylene sulfonate is low. Environmental Effects Environmental Exposures Sodium xylene sulfonate is anticipated to be readily biodegradable and has low potential for bioaccumulation. Volatilization from water surfaces is not expected. Risk Management Recommendations Exposure to sodium xylene sulfonate in the workplace can be controlled by sufficient ventilation, proper handling and storage techniques, and the use of appropriate personal protective equipment as recommended in the SDS.

 

A selection of occupational exposure limits are provided, below. • No occupational exposure limit identified. Sodium xylene sulfonate is used in liquid household detergents and shampoos, in degreasing compounds and printing pastes used in the textile industry in agents used to extract pentosans and lignin in the paper industry, and as a glue additive in the leather industry. When handled responsibly, sodium xylene sulfonate the potential for eye irritation can be minimized, allowing consumers and workers to use materials containing sodium xylene sulfonate safely. STEPANATE SXS is an anionic surfactant used in liquid detergent, heavy duty cleaning, wax stripping, dishwashing detergent formulations and textile applications. It functions as a solubilizer, coupling agent and cloud point depressant.

Sodium xylene sulfonate is a hydrotrope, an organic compound that increases the ability of water to dissolve other molecules. Sodium xylene sulfonate is a low hazard material and risk of adverse health effects associated with both occupational and consumer use of this chemical is anticipated to be low. Sodium Xylene Sulfonate is a surfactant found in personal care products, primarily in shampoos, because of its ability to serve as a claritant or wetting agent that helps a formula spread more easily and ensure efficient cleansing.. It is sodium xylene sulfonate classified as a hydrotrope, or an organic compound that increases the ability of water to dissolve other molecules. Because of Sodium Xylene Sulfonate's dissolving abilities, it is often added to shampoos as a thickening agent that helps suspend other ingredients, clearing out the cloudy look of a formula .

 

 

Functions:Sodium Xylene Sulfonate is a surfactant found in personal care products, primarily in shampoos, because of its ability to serve as a claritant or wetting agent that helps a formula spread more easily and ensure efficient cleansing, according to Johnson& Johnson. It is classified as a hydrotrope, or an organic compound that increases the ability of water to dissolve other molecules. Because of Sodium Xylene Sulfonate's dissolving abilities, it is often added to shampoos as a thickening agent that helps suspend other ingredients, clearing out the cloudy look of a formula.
Safety Measures/Side Effects:Sodium Xylene Sulfonate is considered a low hazard ingredient by the

 

 

Cosmetics Database, which has mild concerns regarding organ system toxicity and skin and eye irritation. One or more animal studies sodium xylene sulfonate showed liver effects and skin irritation at high doses that are unlike those found in shampoos or other cleansing products.The MSDS for Sodium Xylene Sulfonate finds that it is "Hazardous in case of inhalation (lung irritant). Slightly hazardous in case of skin contact (irritant, permeator), of eye contact (irritant), of ingestion, Non-corrosive for skin.

 

Non-corrosive to the eyes. Non-corrosive for lungs." It notes that it is not carcinogenic or mutagenic.
Spolapon XS Na is a hydrotropic substance used as a coupling agent, viscosity modifier, solubilizer and cloud point and crystallization temperature depressant in liquid cleaning, washing and laundry detergents.Most commonly Spolapon sodium xylene sulfonate Na is used in heavy duty cleaners, wax strippers, dishwashing liquids, hard surface cleaners and metalworking cleaners.Hydrotropic properties of Spolapon XS Na are utilized for reducing the cloud point and crystallization temperature of complex blends. Solubilizing properties of the product can substitute function of a solvent in final formulations.Spolapon XS Na serves also as an anti-caking agent in the process of spray drying of detergents and many other industrial applications. A hydrotrope is a compound that solubilizes hydrophobic compounds in aqueous solutions by means other than micellar solubilization. Typically, hydrotropes consist of a hydrophilic part and a hydrophobic part (similar to surfactants), but the hydrophobic part is generally too small to cause spontaneous self-aggregation. Hydrotropes do not have a critical concentration above which self-aggregation spontaneously starts to occur (as found for micelle- and vesicle-forming surfactants, which have a critical micelle concentration (cmc) and a critical vesicle concentration (cvc)). Instead, some hydrotropes aggregate in a step-wise self-aggregation process, gradually increasing aggregation size. However, many hydrotropes do not seem to self-aggregate at all, unless a solubilizate has been added. Examples of hydrotropes include urea, tosylate, cumenesulfonate and xylenesulfonate.

 

The term hydrotropy was originally put forward by Carl Neuberg to describe the increase in the solubility of a solute by the addition of fairly high concentrations of alkali metal salts of various organic acids. However, the term has been used in the literature to designate non-micelle-forming substances, either liquids or solids, organic or inorganic, capable of solubilizing insoluble compounds.The chemical structure of sodium xylene sulfonate the conventional Neuberg's hydrotropic salts (proto-type, sodium benzoate) consists generally of two essential parts, an anionic group and a hydrophobic aromatic ring or ring system. The anionic group is involved in bringing about high aqueous solubility, sodium xylene sulfonate which is a prerequisite for a hydrotropic substance. The type of anion or metal ion appeared to have a minor effect on the phenomenon.[1]

 

On the other hand, planarity of the hydrophobic part has been emphasized as an important factor in the mechanism of hydrotropic solubilization.To form a hydrotrope, an aromatic hydrocarbon solvent is sulfonated, creating an aromatic sulfonic acid. It is then neutralized with a base.Additives may either increase or decrease the solubility of sodium xylene sulfonate a solute in a given solvent. These salts that increase solubility are said to ‘salt in' the solute and those salts that decrease the solubility ‘salt out' the solute. The effect of an additive depends very much on the influence it has on the structure of water or its ability to compete with the solvent water molecules.

 

A convenient quantitation of the effect of a solute additive on the solubility of another solute may be obtained by the Setschetow equation.Hydrotropes sodium xylene sulfonates are in use industrially and commercially in cleaning and personal care product formulations to allow more concentrated formulations of surfactants. About 29,000 metric tons are produced (i.e., manufactured and imported) annually in the US.[4] Annual production (plus importation) in Europe and Australia is approximately 17,000 and 1,100 metric tons, respectively.Common products containing a hydrotropes include laundry detergents, surface cleaners, dishwashing detergents, liquid soaps, shampoos and conditioners.They are coupling agents, sodium xylene sulfonate used at concentrations from 0.1-15% to stabilize the formula, modify viscosity and cloud-point, reduce phase separation in low temperatures, and limit foaming. Ammonium Cumenesulfonate, Ammonium Xylenesulfonate, Calcium Xylenesulfonate, Potassium Cumenesulfonate, Potassium Toluenesulfonate, Potassium Xylenesulfonate, Sodium Cumenesulfonate, Sodium Toluenesulfonate, and Sodium Xylenesulfonate are cleansing agents. The Xylenesulfonates and Toluenesulfonates are made from Xylenesulfonic Acid and Toluenesulfonic Acid.

these ingredients, Ammonium Xylenesulfonate and Sodium Xylenesulfonate are most likely to be found cosmetics and personal care products including shampoos, hair conditioners, soaps and detergents, and bath products. Sodium xylene sulfonate (or its ammonium cousin) are hydrotropes -- organic compounds that increase the ability of water to dissolve other molecules. Xylenesulfonates are used in detergents and shampoos in amounts of up to 10% of the product.They are surfactants, but they are usually added to thicken a mixture like shampoo, and to help keep some other ingredients in solution. This sodium xylene sulfonate makes the product clear or transparent, as the cloudy precipitates are put back into solution.

 

Sodium xylene sulfonate is a hydrotrope, an organic compound that increases the ability of water to dissolve other
molecules. Sodium xylene sulfonate is a low hazard material and risk of adverse health effects associated with both
occupational and consumer use of this chemical is anticipated to be low.


Name: Sodium xylene sulfonate
Brand Names: Not applicable
Chemical name (IUPAC): Sodium dimethylbenzenesulfonate
CAS number(s): 1300-72-7
EC number: 215-090-9
Molecular formula: C8H9NaO3S

Sodium xylene sulfonate is used in liquid household detergents and shampoos, in degreasing compounds and printing pastes used in the textile industry. It is also a surfactant found in personal care products, primarily in shampoos, because of its ability to serve as a claritant or wetting agent that helps a formula spread more easily. Sodium xylene sulfonate is also used to extract pentosans and lignin in the paper industry, and as a glue additive in the leather industry.

 

The following section describes possible exposure scenarios and hazards associated with sodium xylene sulfonate. The exposure assessment describes both the amount of and the frequency with which a chemical substance reaches a person, a population of people, or the environment. Hazard refers to the inherent properties of a substance that make it capable of causing harm to human health or the environment. The safety assessment reports the possibility of a harmful event arising from exposure to a chemical or physical agent under specific conditions. Just because a substance may possess potentially harmful properties does not mean that it automatically poses a risk. It is not possible to make that determination without understanding the exposure.Sodium xylene sulfonate is used in liquid household detergents and shampoos. Therefore, consumer oral and dermal exposures could occur when using products that contain sodium xylene sulfonate in the product formulations. In industrial settings, sodium xylene sulfonate is manufactured and handled in closed processes as much as possible, which ensures that worker exposure is minimized. When there is potential for exposure, during loading, unloading, sampling or during maintenance operations, exposure to sodium xylene sulfonate can be further minimized by the proper use of personal protective equipment.

 

Sodium xylene sulfonate is low for both acute and repeat dose toxicity. It can cause eye irritation but is not anticipated to result in skin irritation or sensitization. Sodium xylene sulfonate is not associated with reproductive toxicity, genotoxicity/mutagenicity or carcinogenicity.

 

Sodium xylene sulfonate is used in liquid household detergents and shampoos. Risk to human health following exposure is unlikely due to the low toxicity of this material. Direct contact with the eyes should be avoided.

 

In industrial settings, sodium xylene sulfonate is manufactured and handled primarily in closed processes which limit exposure. Based on good manufacturing processes and industrial hygiene, the occupational health risk associated with sodium xylene sulfonate is low.

Sodium xylene sulfonate is anticipated to be readily biodegradable and has low potential for bioaccumulation. Volatilization from water surfaces is not expected.

 

Based on the available data, sodium xylene sulfonate is of low toxicity to aquatic organisms. It is readily biodegradable and has a low potential for bioaccumulation. Therefore, minor releases into the aquatic environment are not anticipated to result in adverse effects.

 

Sodium xylene sulfonate is used in liquid household detergents and shampoos, in degreasing compounds and printingpastes used in the textile industry in agents used to extract pentosans and lignin in the paper industry, and as a glue additive in the leather industry. When handled responsibly, the potential for eye irritation can be minimized, allowing consumers and workers to use materials containing sodium xylene sulfonate safely.

 

Sodium xylenesulfonate is used as a hydrotrope, an organic compound that increases the ability of water to dissolve other molecules. Sodium xylenesulfonate is a component in a variety of widely used shampoos and liquid household detergents where it can constitute up to 10% of the total solution. Because of its widespread use, the potential for human exposure to sodium xylenesulfonate is great.

 

Male and female F344/N rats and B6C3F1 mice were administered sodium xylenesulfonate in water or 50% ethanol dermally for 17 days, 14 weeks, or 2 years. Genetic toxicology studies were conducted in Salmonella typhimurium, L5178Y mouse lymphoma cells, and cultured Chinese hamster ovary cells. 17-DAY STUDY IN RATS: Groups of five male and five female rats were administered 300 mL of 0, 5, 15, 44, 133, or 400 mg/mL sodium xylenesulfonate in distilled water by dermal application 5 days per week for 17 days. All rats survived to the end of the study. Final mean body weights and body weight gains of dosed rats were similar to those of the control groups.

 

Dermal applications of 300 mL of 5, 15, 44, 133, and 400 mg/mL delivered average daily doses of approximately 10, 30, 90, 260, and 800 mg sodium xylenesulfonate/kg body weight to males and 13, 40, 120, 330, and 1,030 mg/kg to females. Clinical findings generally involved the skin of dosed animals and included tan or brown skin discoloration and crusty white deposits (presumed to be dried chemical) at the site of application. Neither of these observations were considered significant findings. The relative liver weights of 133 and 400 mg/mL male and female rats were significantly greater than those of the control groups, but the absolute liver weights were not increased and the biological significance of the relative differences in liver weight was unclear. In males and females, the few lesions observed grossly and microscopically were generally attributed to repeated clipping and were not considered related to chemical administration. 17-DAY

 

STUDY IN MICE: Groups of five male and five female mice were administered 100 mL of 0, 5, 15, 44, 133, or 400 mg/mL sodium xylenesulfonate in distilled water by dermal application 5 days per week for 17 days. All mice survived to the end of the study. Final mean body weights and body weight gains of dosed mice were similar to those of the controls. Dermal applications of 5, 15, 44, 133, and 400 mg/mL delivered average daily doses of approximately, 20, 60, 190, 540, and 1,600 mg sodium xylenesulfonate/kg body weight to males and 26, 80, 220, 680, and 2,000 mg/kg to females. Clinical findings included crusty white deposits (presumed to be dried chemical) at the site of application in two 133 mg/mL males and in all 400 mg/mL males and females. The absolute and relative liver weights of 15 and 44 mg/mL males and 400 mg/mL males and females were significantly greater than those of the control groups, but the biological significance of these differences was unclear. The few skin lesions observed grossly and microscopically in males and females were generally attributed to repeated clipping and were not considered related to chemical administration. 14-WEEK STUDY IN RATS: Groups of 10 male and 10 female rats were administered 300 mL of 0, 5, 15, 44, 133, or 400 mg/mL sodium xylenesulfonate in 50% ethanol by dermal application for 14 weeks. For special hematology and clinical pathology studies, additional groups of 10 male and 10 female rats were administered 0, 5, 15, 44, 133, or 400 mg/mL sodium xylenesulfonate in 50% ethanol by dermal application for 14 weeks. All rats survived to the end of the study. Final mean body weights and body weight gains of dosed male and female rats were similar to those of the control groups. Dermal applications of 5, 15, 44, 133, and 400 mg/mL delivered average daily doses of approximately 6, 20, 60, 170, and 500 mg sodium xylenesulfonate/kg body weight to males and 10, 30, 90, 260, and 800 mg/kg to females. The only notable clinical finding was brown discoloration of the skin at the site of application in dosed animals.

 

Hemaation in dosed animals. Hematology and clinical chemistry parameters of dosed groups of males and females were significantly different from those of the controls in several instances, but these differences were sporadic and did not demonstrate a treatment relationship. The absolute and relative liver weights of males receiving 44, 133, or 400 mg/mL were significantly less than those of the control group, but the biological significance of these differences was unclear, and there were no treatment-related histopathologic effects in the liver. There were no significant differences in liver weights in female rats. Minimal hyperplasia of the epidermis at the site of application occurred in both male and female rats in the control group as well as most dosed groups. The incidence of epidermal hyperplasia in 400 mg/mL males was possibly chemical related. 14-Week Study in Mice: Groups of 10 male and 10 female mice were administered 100 mL of 0, 5, 15, 44, 133, or 400 mg/mL sodium xylenesulfonate in 50% ethanol by dermal application for 14 weeks. There were no chemical-related deaths. The mean body weight gain of the 400 mg/mL males was significantly greater than that of the control group. Dermal applications of 5, 15, 44, 133, and 400 mg/mL delivered average daily doses of approximately 17, 40, 140, 440, and 1,300 mg sodium xylenesulfonate/kg body weight to males and 20, 60, 170, 530, and 1,630 mg/kg to females. There were no clinical findings related to sodium xylenesulfonate administration. Epidermal hyperplasia occurred in one 44 mg/mL female, two 133 mg/mL males, five 400 mg/mL males, and four 400 mg/kg females. Hyperplasia of the epidermis in 400 mg/mL males and females was probably related to chemical administration. Chronic inflammation of the skin occurred primarily in the control groups of males and females.

 

These lesions consisted of mononuclear inflammatory cells in the dermis. 2-YEAR STUDY IN RATS: Groups of 50 male and 50 female rats were dermally administered 0, 60, 120, or 240 mg sodium xylenesulfonate/kg body weight in 50% ethanol for 104 weeks. Survival, Body Weights, and Clinical Findings: Survival of dosed males and females was similar to that of the control groups. Mean body weights of dosed males and females were similar to those of the controls throughout the study. In male groups, there were no clinical findings considered treatment related. In females, clinical findings were limited to irritation at the site of application in one control female, four 120 mg/kg females, and two 240 mg/kg females. Pathology Findings: There were no neoplasms at any site (including the skin) that were considered treatment related.Low incidences of hyperplasia of the epidermis at the site of application occurred in males in the 60, 120, and 240 mg/kg groups. Low incidences of hyperplasia of the epidermis at the site of application also occurred in females in the 120 and 240 mg/kg groups, and they occurred with a significant positive trend. Low incidences of hyperplasia of the sebaceous gland occurred in control and 60 mg/kg males and in control, 120 mg/kg, and 240 mg/kg females. 2-YEAR STUDY IN MICE: Groups of 50 male and 50 female mice were dermally administered 0, 182, 364, or 727 mg sodium xylenesulfonate/kg body weight in 50% ethanol for 104 to 105 weeks. Survival, Body Weights, and Clinical Findings: Survival of dosed males and females was similar to that of the control groups.

 

Mean body weights of dosed males and females were generally similar to those of the controls throughout the study; however, the mean body weights of 727 mg/kg females were greater than those of the control group from week 85 to week 97. With the exception of irritation at the site of application in one 364 mg/kg female, there were no clinical findings related to sodium xylenesulfonate administration. Pathology Findings: There were no neoplasms at any site (including the skin) that were considered treatment related.Hyperplasia of the epidermis occurred in control,364 mg/kg, and 727 mg/kg males and in control and dosed females. In male mice, the incidences occurred with a significant positive trend. Focal ulceration occurred in one 727 mg/kg male and in one female in each dose group. In males and females from control and dosed groups, the incidences of hepatocellular adenoma, hepatocellular carcinoma, and hepato- cellular adenoma or carcinoma (combined) were generally higher than those expected by spontaneous occurrence.

 

The incidences of hepatocellular neoplasms in some groups of males and females exceeded the NTP historical control range. Male mice had a pattern of nonneoplastic liver lesions along with silver stained positive helical organisms within the liver which suggests an infection with Helicobacter hepaticus. The findings in this study of sodium xylenesulfonate were not considered to have been significantly impacted by the infection with H. hepaticus or its associated hepatitis. GENETIC TOXICOLOGY: Sodium xylenesulfonate was not mutagenic in Salmonella typhimurium strain TA98, TA100, TA1535, or TA1537 with or without induced liver S9. Equivocal results were obtained in a mutation assay with mouse lymphoma cells in the presence of induced S9; no evidence of mutagenicity was noted without S9 in this assay. In cytogenetic tests with sodium xylenesulfonate in cultured Chinese hamster ovary cells, significant increases in sister chromatid exchanges were observed in the absence of S9 only, and no increases in chromosomal aberrations were observed with or without S9. CONCLUSIONS: Under the conditions of these 2-year dermal studies, there was no evidence of carcinogenic activity of sodium xylenesulfonate in male or female F344/N rats administered 60, 120, or 240 mg/kg or in male or female B6C3F1 mice administered 182, 364, or 727 mg/kg. Increased incidences of epidermal hyperplasia in female rats and male mice may have been related to exposure to sodium xylenesulfonate.

 

Sodium Xylene Sulfonate is a surfactant found in personal care products, primarily in shampoos, because of its ability to serve as a claritant or wetting agent that helps a formula spread more easily and ensure efficient cleansing, according to Johnson& Johnson. It is classified as a hydrotrope, or an organic compound that increases the ability of water to dissolve other molecules. Because of Sodium Xylene Sulfonate's dissolving abilities, it is often added to shampoos as a thickening agent that helps suspend other ingredients, clearing out the cloudy look of a formula (Sci-Toys.com).

 

Sodium Xylene Sulfonate is a surfactant found in personal care products, primarily in shampoos, because of its ability to serve as a claritant or wetting agent that helps a formula spread more easily and ensure efficient cleansing, according to Johnson& Johnson. It is classified as a hydrotrope, or an organic compound that increases the ability of water to dissolve other molecules. Because of Sodium Xylene Sulfonate's dissolving abilities, it is often added to shampoos as a thickening agent that helps suspend other ingredients, clearing out the cloudy look of a formula (Sci-Toys.com).

 

Sodium Xylene Sulfonate is FDA approved, and is seen in shampoos and other products in concentrations up to 10%.

Sodium Xylene Sulfonate is considered a low hazard ingredient by the Cosmetics Database, which has mild concerns regarding organ system toxicity and skin and eye irritation. One or more animal studies showed liver effects and skin irritation at high doses that are unlike those found in shampoos or other cleansing products.

 

The MSDS for Sodium Xylene Sulfonate finds that it is "Hazardous in case of inhalation (lung irritant). Slightly hazardous in case of skin contact (irritant, permeator), of eye contact (irritant), of ingestion, Non-corrosive for skin. Non-corrosive to the eyes. Non-corrosive for lungs." It notes that it is not carcinogenic or mutagenic.
INCI Name Sodium Xylene Sulfonate
CTFA Name Sodium Xylene Sulfonate SXS-40
CAS Number 1300-72-7
Application Detergent & Cleaners

 

Use Tainolin SXS-40, dissolved in water can increase the solubility for low-soluble organic matter, lower down the cloud point of the aqueous formulated products, and reduce the viscousity of the aqueous products.

 

It is used industrially and compercially in cleaning product formulations to allow more concentrated formulations of surfactants. Industrial uses include laundry detergents, surface cleaners, and dishwashing detergents. Jempak SXS Liquid; Sodium Xylene Sulfonate 40%; Stepanate SXS-40; Sodium Dimethylbenzenesulfonate; Benzenesulfonicacid, dimethyl-,sodiumsalt.

 

The specific refraction, specific volume, and viscosity of systems containing sodium alkyl-ether-sulfate(NaEOS)(10, 20, 25, 27.5, and 30% w/w)and sodium xylene-sulfonate(NaXS) (1, 2, and 3% w/w) has been studied in the temperature range of 278 to 313 K.From this study, the following conclusions may be drawn:All systems show Newtonian behavior for the shear-rate range 0 to 28.5 s-1.The addition of sodium xylene-sulfonate produces a progressive viscosity reduction for a constant concentration of sodium alkyl-ether-sulfate.

 

Sodium xylene sulfonate es un agente humectante que también puede encontrarse en productos para el cuidado del cabello y limpiadores. Lo utilizamos en nuestros productos para ayudar a que una fórmula se extienda por una superficie y haga más eficiente la limpieza. Sodium xylene sulfonate también puede usarse como agente solubilizante que asegura una distribución uniforme de los ingredientes en un producto para que actúe mejor.

 

The applicable subheading for sodium xylene sulfonate will be 2904.10.3200, Harmonized Tariff Schedule of the United States (HTS), which provides for other aromatic sulfonated, nitrated or nitrosated derivatives of hydrocarbons, whether or not halogenated: products described in additional U.S. note 3 to section VI. The rate of duty will be 13.5 percent ad valorem.

 

Vapor pressures of two fragrance materials in aqueous solutions of polyvinylpyrrolidone and sodium xylenesulfonate were determined using gas chromatography of head space samples. The association between polymer and hydrotrope was evaluated from the values of surface tension and electrical conductance. The result showed an association of the hydrotrope and the polymer leading to enhanced surface tension after addition of polymer to hydrotope solutions in a certain hydrotope concentration range. The polymer hydrotope association structure resulted in a reduction of fragrance vapor pressure due to solubilization of the fragrance into the association structure.


Three subchronic 90-day feeding studies in rats were conducted; two with sodium xylene sulfonate (2 and 54) and the other with sodium cumene sulfonate.

In the second study (54), five male and five female rats and mice were exposed per dose level to sodium xylene sulfonate as 0, 0.125%, 0.25%, 0.5%, 1% and 2% in the diet. A nuclear magnetic resonance spectrum was run on the test material to determine purity. The conclusion of this analysis was that the major component of the test material was xylene sulfonate; although an exact percent purity was not stated in the report.

 

Hydrotropes have been assessed for mutagenic potential in a variety of in vitro and in vivo assays. Specifically Ames assay, mouse lymphoma, sister chromatid exchange, and chromosome aberration assays with sodium xylene sulfonate and an Ames assay with calcium xylene sulfonate, and mouse micronucleus cytogenetic assays with calcium xylene sulfonate and sodium cumene sulfonate, have been reported.

 

The mutagenic potential of sodium xylene sulfonate (51), calcium xylene sulfonate (21) and sodium cumene sulfonate (8), at 65%, 31% and 40% active ingredient, respectively, were evaluated in the bacterial reverse mutation (Ames) assay using Salmonella typhimurium strains TA 98, 100, 1535, 1537 and 1538. There was no evidence of mutagenicity observed for any of the three compounds with and without metabolic activation. The negative results for sodium xylene sulfonate are corroborated by an Albright & Wilson study reported in the IUCLID .

 

Technical grade (65% a.i.) sodium xylene sulfonate was tested for mutagenicity potential in F344/N rats and B6C3F1 mice using a dermal exposure and L5178Y mouse lymphoma cells (51). There were two independent tests with duplicate cultures per treatment.

 

Technical grade (65% a.i.) sodium xylene sulfonate was tested at 500 - 5000 µg/mL using Chinese hamster ovary cells (51). There were two independent tests with an exposure period of 25.5 hours. The results indicated clastogenic activity (cell cycle delay) without metabolic activation at 2513 - 5000 µg/mL which was addressed by lengthening incubation time to 32.5 hours to ensure a sufficient number of scorable (second-division metaphase) cells.

Technical grade (65% a.i.) sodium xylene sulfonate was tested for mutagenicity potential in F344/N rats and B6C3F1 mice using a dermal exposure and Chinese hamster ovary cells (51). Test concentrations were 2513, 3750 and 5000 µg/mL. Exposure with S9 activation was 2 hours (+ 10 hr incubation) and 18 hours without S9 activation. There was no mutagenic activity with and without metabolic activation.

 

Three mouse micronucleus cytogenetic assays were reported; one with calcium xylene sulfonate (35) and the other two with sodium cumene sulfonate (9, 12). The first study (35) used a single intra-peritoneal (i.p.) administration at 0, 145, 290 and 580 mg a.i./kg bw given to 6-8 week old mice (5 per sex per dose). The second study (12) used a single oral dose administration at 0 and 4467 mg a.i./kg bw given to 24-30 gram mice (5 per sex per dose). The third study (9) used total oral doses of 0, 400, 2000 and 4000 mg a.i./kg bw delivered gavage in two equal applications 24 hours apart to male and female mice.

 

Technical grade (65% a.i.) sodium xylene sulfonate was tested for mutagenicity potential in F344/N rats and B6C3F1 mice using a dermal exposure and Chinese hamster ovary cells (51). Test concentrations were 2513, 3750 and 5000 µg/mL. Exposure with S9 activation was 2 hours (+ 10 hr incubation) and 18 hours without S9 activation.

There was no mutagenic activity with and Chronic toxicity/carcinogenicity studies are reported for both rats and mice dermally exposed for 2 years to sodium xylene sulfonate. without metabolic activation.

 

Fifty male and 50 female rats (F344/N) and mice (B6C3F1) received dermal application (5 days per week to clipped skin) of technical grade sodium xylene sulfonate (65% a.i.) in 2-year carcinogenicity studies (51). Dosing was done using a 50% ethanol vehicle. Doses in the rat study were 0, 60, 120 and 240 mg a.i./kg bw and 0, 182, 364 and 727 mg a.i./kg bw in the mouse study. Observations were as per OECD 453 Guideline with the exception of clinical signs recorded monthly, and no observations of food consumption (feeding was ad libitum), blood parameters, urinalysis and organ weights were undertaken. Stability of the test compound in ethanol was confirmed. Body weight gain was not affected by the exposures in either species.

 

No multi-generation reproduction toxicity studies are reported for hydrotropes. The 91-day oral rat feeding study with sodium cumene sulfonate (18), the 90-day feeding study with sodium xylene sulfonate (2) and the dermal studies with sodium xylene sulfonate (51).

 

Developmental toxicity in rats, including fertility, was evaluated for calcium xylene sulfonate (32). Female rats (Crl:CD) were mated with untreated males (1/1) from the same strain. Calcium xylenesulfonate (31% a.i.) was administered via gavage to 30 female rats (~87 days old) per dose at 0, 150, 1500 and 3000 mg/kg bw in water vehicle at a dosing volume of 10 ml/kg during days 6 to 15.
KUALIMATE SXS 40
Purity: 40%

 

Chemical Name: Sodium Xylene Sulfonate
Product Application: Hydrotrope, solubilizer, coupling agent, cloud point depressant, viscosity reducer, the anti-caking agent in powdered detergent.
Form at 25: liquid
Packing: 225 kg drum or 1150 kg tote

 

KUALIMATE SXS 93
Purity: 93%
Chemical Name: Sodium Xylene Sulfonate
Product Application: Hydrotrope, solubilizer, coupling agent, cloud point depressant, viscosity reducer, the anti-caking agent in powdered detergent.
Form at 25: solid,powder
Packing: 25 or 30 kg bag


Cas No : 28348-53-0 Bulaşık makinesi deterjanlarında ve sıvı deterjanlarda çözücü ve viskozite düzenleyici olarak kullanılmaktadır.
Deterjanlarda kullanımı % 0,5 -5 arasında değişmektedir.


Navcusol 90 Sodyum Kümen Sülfonat Ekstra Chem Pure 1 kg

Genel Bilgi: Kimyasal formülü C9H11NaO3S olan toz ve berrak görünümlü higroskobik sıvı formunda bir kimyasaldır.

Üretim ve Reaksiyonları: Kümen ticari üretimi propilen ile benzen içinde Friedel-Crafts alkilasyonu gereğince üretilmektedir.Kümen üretici benzen için
küresel talebinin yaklaşık % 20 sini oluşturmaktadır. Sodyum sülfonatların uygun şartlarda kümen ile etkileşim ve reaksiyonlarıyla oluşabilmektedir.

Kullanım Alanları: Deterjan yapımında % 0,5 -5 oranlarında ara faz çözücü olarak,bulaşık makinesi deterjanlarında ve sıvı deterjanlarda çözücü ve
viskozite düzenleyici olarak kullanılmaktadır.


Kimyasal formülü C9H11NaO3S olan toz ve berrak görünümlü higroskobik sıvı formunda bir kimyasaldır. Kümen ticari üretimi propilen ile
benzen içinde Friedel-Crafts alkilasyonu gereğince üretilmektedir. Kümen üretici benzen için küresel talebinin yaklaşık % 20 sini oluşturmaktadır.


Sodyum Ksilen Sülfonat sıklaştırıcı bir ajan olarak şampuanlara sıklıkla eklenen bir yüzey aktif maddedir; genellikle şampuanlarda olmak üzere
kişisel bakım ürünlerinde bulunur. Johnson & Johnson'a göre, bir formülün daha kolay yayılmasına yardımcı olan ve etkili temizlik sağlayan bir
klartan veya ıslatıcı ajan olarak hizmet edebilir. Eşanlamlılar: Ksilenesülfonik asitler, sodyum tuzları; SXS; Sodyum dimetilbenzensülfonat.
CAS No: 1300-72-7. Moleküler Formül: C8H9NaSO3 Molar Kütle: 208.21 g / mol.


Sodyum ksilenesülfonat, suyun diğer molekülleri çözme yeteneğini arttıran organik bir bileşik olan hidrotrop olarak kullanılır.
Sodyum ksilenesülfonat, yaygın olarak kullanılan çeşitli şampuanlarda ve sıvı ev deterjanlarında, toplam çözeltinin% 10'unu oluşturabildiği bir bileşendir.
Yaygın kullanımı nedeniyle, insanların sodyum ksilenesülfonata maruz kalma potansiyeli mükemmeldir. Erkek ve dişi F344 / N sıçanlarına ve B6C3F1 farelerine 17 gün,
14 hafta veya 2 yıl boyunca su veya% 50 etanol içinde sodyum ksilenesülfonat uygulandı. Genetik toksikoloji çalışmaları Salmonella typhimurium, L5178Y fare lenfoma
hücrelerinde ve kültürlenmiş Çin hamsteri yumurtalık hücrelerinde gerçekleştirilmiştir.


Beş erkek ve beş dişi sıçan grubuna 300 mL 0, 5, 15, 44, 133, veya damıtılmış suda 400 mg / mL sodyum ksilenesülfonat 17 gün boyunca
haftada 5 gün dermal uygulama ile. Tüm sıçanlar çalışmanın sonuna kadar hayatta kaldı. Dozlanan sıçanların nihai ortalama vücut ağırlıkları ve vücut ağırlığı
kazançları kontrol gruplarına benzerdi. 300 mL 5, 15, 44, 133 ve 400 mg / mL'lik dermal uygulamalar, erkeklere ve günlük 13, 40, 120 vücut ağırlığına göre
yaklaşık 10, 30, 90, 260 ve 800 mg sodyum ksilenesülfonat / kg ortalama günlük dozlar verdi. , 330 ve 1.030 mg / kg kadınlara. Klinik bulgular genellikle dozlanan
hayvanların derisini içermekteydi ve uygulama yerinde ten rengi veya kahverengi deri renk değişikliği ve huysuz beyaz birikintileri (kuru kimyasal olduğu
varsayılmaktadır) içermiştir.

Bu gözlemlerin hiçbiri önemli bulgular olarak kabul edilmedi. 133 ve 400 mg / mL erkek ve dişi sıçanların nispi karaciğer ağırlıkları,
kontrol gruplarına göre anlamlı olarak daha yüksekti, fakat mutlak karaciğer ağırlıkları artmadı ve karaciğer ağırlığındaki nispi farklılıkların biyolojik önemi net
değildi. Erkeklerde ve kadınlarda, kaba ve mikroskopik olarak gözlenen az sayıda lezyon genellikle tekrarlanan kırpmaya bağlandı ve kimyasal uygulama ile ilgili olarak değerlendirilmedi. Farelerde 17 Günlük Çalışma: Beş erkek ve beş dişi fareden oluşan gruplara, distile su içinde 17 gün boyunca haftada 5 gün 100 ml 0, 5, 15, 44, 133 veya 400 mg / mL sodyum ksilenesülfonat uygulandı. . Tüm fareler çalışmanın sonuna kadar hayatta kaldı. Dozlanan farelerin nihai ortalama vücut ağırlıkları ve vücut ağırlığı kazançları kontrol grubuna benzerdi. 5, 15, 44, 133 dermal uygulamaları, ve 400 mg / mL, erkeklere ortalama günlük dozlar, yaklaşık 20, 60, 190, 540 ve 1.600 mg sodyum ksilenesülfonat / kg, erkeklere 26, 80, 220, 680 ve 2.000 mg / kg verdi. Klinik bulgular, uygulama yerinde iki 133 mg / mL erkekte ve 400 mg / mL erkek ve kadınlarda huysuz beyaz tortuları (kurutulmuş kimyasal olduğu varsayılmıştır) içermektedir. 15 ve 44 mg / mL erkek ve 400 mg / mL erkek ve kadınların mutlak ve göreceli karaciğer ağırlıkları, kontrol gruplarına göre anlamlı olarak daha yüksekti, ancak bu farklılıkların biyolojik önemi belirsizdi. Erkeklerde ve kadınlarda kaba ve mikroskobik olarak
gözlenen az sayıda cilt lezyonu genellikle tekrarlanan kırpmaya bağlandı ve kimyasal uygulama ile ilgili olarak düşünülmedi.


10 erkek ve 10 dişi sıçanın grubuna, 14 hafta boyunca% 50 etanol içinde 300 mL 0, 5, 15, 44, 133 veya 400 mg / mL sodyum ksilenesülfonat
uygulandı. Özel hematoloji ve klinik patoloji çalışmaları için 10 erkek ve 10 dişi sıçanın ilave gruplarına, 14 hafta boyunca% 50 etanol içinde 0, 5, 15, 44, 133
veya 400 mg / mL sodyum ksilenesülfonat uygulandı. Tüm sıçanlar çalışmanın sonuna kadar hayatta kaldı. Dozlanan erkek ve dişi sıçanların nihai ortalama
vücut ağırlıkları ve vücut ağırlığı kazançları kontrol gruplarına benzerdi. 5, 15, 44, 133 ve 400 mg / mL'lik dermal uygulamalar, erkeklere ortalama günlük
dozlar olarak yaklaşık 6, 20, 60, 170 ve 500 mg sodyum ksilenesülfonat / kg ve 10, 30, 90, 260, ve kadınlara 800 mg / kg. Tek önemli klinik bulgu, dozlanan
hayvanlarda uygulama bölgesinde cildin kahverengi renk değişimi idi.


Dozlanan hayvanlarda hemalasyon. Dozlanan erkek ve dişi grupların hematoloji ve klinik kimya parametreleri, birkaç durumda kontrollerden önemli ölçüde farklıydı,
ancak bu farklılıklar sporadikti ve bir tedavi ilişkisi göstermedi. 44, 133 veya 400 mg / mL alan erkeklerin mutlak ve nispi karaciğer ağırlıkları, kontrol grubuna
göre anlamlı derecede daha azdı, ancak bu farklılıkların biyolojik önemi belirsizdi ve karaciğerde tedaviyle ilişkili histopatolojik etki yoktu. . Dişi sıçanlarda
karaciğer ağırlıklarında anlamlı bir fark yoktu. Uygulama yerinde epidermisin minimal hiperplazisi, kontrol grubundaki hem erkek hem de dişi sıçanlarda ve çoğu
dozlanmış grupta meydana gelmiştir. 400 mg / mL erkeklerde epidermal hiperplazi insidansı muhtemelen kimyasalla ilişkiliydi.


10 erkek ve 10 dişi fareden oluşan gruplara, 14 hafta boyunca% 50 etanol içinde 100 mL 0, 5, 15, 44, 133 veya 400 mg / mL sodyum ksilenesülfonat uygulandı.
Kimyasallarla ilişkili ölümler olmadı. 400 mg / mL erkeklerin ortalama vücut ağırlığı kazancı, kontrol grubundan anlamlı olarak daha yüksekti. 5, 15, 44, 133 ve
400 mg / mL'lik dermal uygulamalar, erkeklere ortalama günlük dozlar olarak yaklaşık 17, 40, 140, 440 ve 1.300 mg sodyum ksilenesülfonat / kg vücut ağırlığı ve 20,
60, 170, 530, ve kadınlara 1.630 mg / kg. Sodyum ksilenesülfonat uygulaması ile ilgili klinik bulgu yoktu. Epidermal hiperplazi, bir 44 mg / mL dişi, iki
133 mg / mL erkek, beş 400 mg / mL erkek ve dört 400 mg / kg dişinde meydana geldi. 400 mg / mL erkek ve kadınlarda epidermisin hiperplazisi muhtemelen kimyasal
uygulama ile ilişkiliydi. Cildin kronik iltihabı öncelikle erkek ve kadınların kontrol gruplarında meydana geldi. Bu lezyonlar dermisteki mononükleer inflamatuar
hücrelerden oluşuyordu.


50 erkek ve 50 dişi sıçan grubuna, 104 hafta boyunca% 50 etanol içinde 0, 60, 120 veya 240 mg
sodyum ksilenesülfonat / kg vücut ağırlığı dermal olarak uygulandı. Sağkalım, Vücut Ağırlıkları ve Klinik Bulgular: Dozlanan erkeklerin ve kadınların hayatta
kalması kontrol gruplarına benzerdi. Dozlanan erkeklerin ve kadınların ortalama vücut ağırlıkları çalışma boyunca kontrol grubuna benzerdi. Erkek gruplarda
tedaviyle ilişkili kabul edilen klinik bulgu yoktu. Kadınlarda klinik bulgular bir kontrol dişi, dört 120 mg / kg dişi ve iki 240 mg / kg dişi uygulama bölgesinde
tahriş ile sınırlıydı.


Patoloji Bulguları: Herhangi bir bölgede (cilt dahil) tedavi ile ilişkili kabul edilen hiçbir neoplazm yoktu. 60, 120 ve 240 mg / kg
gruplarındaki erkeklerde uygulama yerinde epidermisin düşük hiperplazisi görülmüştür. Uygulama yerinde epidermisin düşük hiperplazisi insidansı
120 ve 240 mg / kg gruplarındaki kadınlarda da ortaya çıkmış ve anlamlı bir pozitif eğilim ile ortaya çıkmıştır. Yağ bezinin hiperplazisi insidansları
kontrol ve 60 mg / kg erkeklerde ve kontrolde 120 mg / kg ve 240 mg / kg kadınlarda meydana geldi. Farelerde 2 Yıllık Çalışma: 50 erkek ve 50 dişi fareden oluşan
gruplara, 104 ila 105 hafta boyunca% 50 etanol içerisinde vücut ağırlığına göre 0, 182, 364 veya 727 mg sodyum ksilenesülfonat / kg vücut ağırlığı uygulanmıştır.
Sağkalım, Vücut Ağırlıkları ve Klinik Bulgular: Dozlanan erkeklerin ve kadınların hayatta kalması kontrol gruplarına benzerdi.

Dozlanan erkek ve kadınların ortalama vücut ağırlıkları genellikle çalışma boyunca kontrollerin ağırlıklarına benzerdi; bununla birlikte, 727 mg / kg'lık kadınların
ortalama vücut ağırlıkları 85 ile 97. haftalar arasında kontrol grubuna göre daha fazlaydı. 364 mg / kg'lık bir kadında uygulama bölgesinde tahriş olması dışında
klinik bulgu yoktu. sodyum ksilenesülfonat uygulamasına ilişkindir. Patoloji Bulguları: Herhangi bir bölgede (cilt dahil) tedavi ile ilişkili kabul edilen neoplazm
yoktu. Epidermisin hiperplazisi kontrol, 364 mg / kg ve 727 mg / kg erkeklerde ve kontrol ve dozlanmış kadınlarda meydana geldi. Erkek farelerde, insidanslar anlamlı
bir pozitif eğilim ile meydana geldi. Her doz grubunda 727 mg / kg erkek ve bir kadında fokal ülserasyon meydana geldi. Kontrol ve doz gruplarından erkek ve
kadınlarda, hepatosellüler adenom, hepatosellüler karsinom ve hepatosellüler adenom veya karsinom (birleşik) insidansları genellikle spontan oluşumdan beklenenden
daha yüksekti. Bazı erkek ve kadın gruplarında hepatosellüler neoplazmların insidansı NTP tarihsel kontrol aralığını aşmıştır. Erkek fareler, karaciğerde gümüş lekeli
pozitif sarmal organizmalar ile birlikte neoplastik olmayan karaciğer lezyonlarına sahipti ve bu da Helicobacter hepaticus ile bir enfeksiyon olduğunu düşündürdü.
Bu sodyum ksilenesülfonat çalışmasındaki bulguların, H. hepaticus veya bununla ilişkili hepatit enfeksiyonu ile önemli ölçüde etkilendiği düşünülmemiştir.


Sodyum ksilenesülfonat, uyarılmış karaciğer S9 olsun veya olmasın Salmonella typhimurium suşu TA98, TA100, TA1535 veya TA1537'de mutajenik değildi. Eksivokal sonuçlar,
uyarılmış S9 varlığında fare lenfoma hücreleri ile bir mutasyon tahlilinde elde edildi; bu tahlilde S9 olmadan mutajenite kanıtı kaydedilmedi. Kültürlenen
Çin hamsteri yumurtalık hücrelerinde sodyum ksilenesülfonat ile sitogenetik testlerde, Sadece S9'un yokluğunda kardeş kromatid değişimlerinde önemli artışlar
gözlendi ve S9 ile veya S9 olmadan kromozomal anormalliklerde artış gözlenmedi. SONUÇLAR: Bu 2 yıllık dermal çalışmaların koşulları altında, 60, 120 veya
240 mg / kg uygulanan erkek veya dişi F344 / N sıçanlarında veya uygulanan erkek veya dişi B6C3F1 farelerinde sodyum ksilenesülfonatın kanserojen aktivitesine
dair bir kanıt yoktu. 364 veya 727 mg / kg.

 

 

 

 

 

Ataman Kimya A.Ş. © 2015 Tüm Hakları Saklıdır.